SROA recently hosted a COVID-19 Q&A webinar session with four Board members. The members discussed what their facilities are doing to manage the CDC guidelines and the changing dynamic of the COVID-19 pandemic. All questions asked during the webinar were from SROA members.
Susan Vannoni, founder and CEO of Radiation Oncology Consulting LLC (ROC), provides some helpful answers in this Q&A to common questions about treatment delivery and management of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). All codes listed in this Q&A are from the AMA CPT.